Literature DB >> 10095146

Sodium nitroprusside prevents oxygen-free-radical-induced pulmonary vasoconstriction in newborn piglets.

X Q Yu1, S Medbo, O D Saugstad.   

Abstract

The aim of the present study was to test whether hypoxanthine-xanthine oxidase (XO) induced a pulmonary vasoconstriction in newborn piglets, and whether this vasoconstriction could be attenuated or abolished by pretreatment of nitric oxide (NO) donor sodium nitroprusside (SNP). Twenty-five anesthetized newborn piglets (1-3 days old) were randomly assigned to the following four groups: the control group received saline intravenously only; the XO group received 0.1 mmol/kg of hypoxanthine subsequent with XO (1.5 U/kg); the SNP group received the same dosages of hypoxanthine/ XO together with SNP intravenously, allopurinol (ALP) group received ALP intravenously prior to hypoxanthine and XO injection. After giving XO, the pulmonary arterial pressure (PAP) and vascular resistance (PVR) increased, while the cardiac index decreased significantly in the XO group. By contrast, these variables were not significantly modified by XO injection in the SNP and ALP groups. The data suggest that oxygen free radicals induce a pulmonary vasoconstriction in newborn piglets, and this vasoconstriction can be prevented by infusion of the NO donor SNP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10095146     DOI: 10.1159/000014110

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  2 in total

1.  Nitric oxide- and nitric oxide donors-induced relaxation and its modulation by oxidative stress in piglet pulmonary arteries.

Authors:  J G López-López; F Pérez-Vizcaíno; A L Cogolludo; M Ibarra; F Zaragozá-Arnáez; J Tamargo
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Mechanisms involved in SNP-induced relaxation and [Ca+]i reduction in piglet pulmonary and systemic arteries.

Authors:  A L Cogolludo; F Pérez-Vizcaíno; F Zaragozá-Arnáez; M Ibarra; G López-López; V López-Miranda; J Tamargo
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.